Johnson & Johnson, Bristol-Myers Squibb, and Pfizer could see sales of their factor Xa drugs Xarelto and Eliquis jump if Portola Pharmaceuticals antidote succeeds in trials.
Johnson & Johnson, Bristol-Myers Squibb, and Pfizer could see sales of their factor Xa drugs Xarelto and Eliquis jump if Portola Pharmaceuticals antidote succeeds in trials.